Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population
NCT00547560
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
GSI-953
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Collaborators
[object Object]